Table 3.
Univariate assessment of predictors of cardiotoxicity.
| Variables | Cardiotoxicity | p value (forecast of cardiotoxicity) | Odds ratios | 95% confidence interval | |
|---|---|---|---|---|---|
| Absent (n = 34) | Present (n = 9) | ||||
| Variation in the LVEF at 3 months (%) | 1.3 ± 7 | 6.7 ± 8 | 0.18 | 5.6 | 0.46–100 |
| Variation in longitudinal strain at 3 months (%) | 4 ± 11 | 16 ± 9 | 0.01 | 501 | 6.8–110.000 |
| Variation in radial strain at 3 months (%) | 3 ± 24 | 23 ± 23 | 0.03 | 251 | 4–40.000 |
| Variation in NT-proBNP at 3 months (%) | 47 ± 245 | 57191± | 0.92 | 1 | 0.65–1.4 |
| Elevation hsTnl at 3 months | 7 (18%) | 6 (68%) | 0.007 | 9 | 1.9–50 |